| 2024 |
TransCode Therapeutics Inc
|
Interim Chief Executive Officer, Director, Vice President, Chief Financial Officer and Principal Accounting Officer |
957.0 K |
124.2 % |
| 2023 |
TransCode Therapeutics Inc
|
Director, Interim Chief Executive Officer, Vice President, Chief Financial Officer and Principal Accounting Officer |
426.9 K |
-23.9 % |
| 2022 |
TransCode Therapeutics Inc
|
Director, Vice President, Chief Financial Officer and Principal Accounting Officer |
560.7 K |
76.5 % |
| 2021 |
TransCode Therapeutics Inc
|
- |
317.6 K |
- |
| 2021 |
TransCode Therapeutics Inc
|
Director, Vice President, Chief Financial Officer and Principal Accounting Officer |
317.6 K |
- |
| 2020 |
TransCode Therapeutics Inc
|
- |
15.4 K |
- |
| 2020 |
TransCode Therapeutics Inc
|
- |
15.4 K |
- |
| 2020 |
TransCode Therapeutics Inc
|
Vice President, Chief Financial Officer, Director |
- |
- |